Is Osteoarthritis Cure — ARPA-H NITRO — Rocket Fuel Or TNT?
The U.S. federal government just unveiled a moonshot to fix osteoarthritis. Rumored to be funded at $1 billion and launched out of the new Advanced Research Project Agency for Health (ARPA-H), the Novel Innovations for Tissue Regeneration in Osteoarthritis, or NITRO program, plans to cure OA in five years. But can it be done?
Considerations For Clinical Trial Success
Advancing to clinical trials is an exciting milestone in drug development — but it can also be daunting. Arm your team with important factors to consider by exploring this infographic.
Flexible Solutions Provide Critical Site Support
Across the pharmaceutical industry, clinical research sites face many challenges. Individual sites vary widely and need flexible, tailor-made solutions that can evolve and adapt to their unique needs.
CHOOSE YOUR OWN ADVENTURE
You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.
- Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here.
|Connect With Clinical Leader:|